China Biologic Products in Secondary Offering

June 8, 2016

Cleary Gottlieb represented the sole bookrunner, Morgan Stanley, in an SEC-registered secondary offering of 2,775,000 shares of common stock of China Biologic Products, Inc. by Warburg Pincus.

The transaction closed on June 8, 2016.

Select a Category

Select a Practice or Industry

Select a role

Select a location

Select a location

Select a location

About Us

Americas

Asia

Europe, Middle East & Africa

China Biologic Products in Secondary Offering